↓ Skip to main content

Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0049279
Pubmed ID
Authors

Javier Ampuero, Isidora Ranchal, David Nuñez, María del Mar Díaz-Herrero, Marta Maraver, José Antonio del Campo, Ángela Rojas, Inés Camacho, Blanca Figueruela, Juan D. Bautista, Manuel Romero-Gómez

Abstract

To investigate the influence of metformin use on liver dysfunction and hepatic encephalopathy in a retrospective cohort of diabetic cirrhotic patients. To analyze the impact of metformin on glutaminase activity and ammonia production in vitro.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 4%
Italy 1 2%
Canada 1 2%
Brazil 1 2%
Unknown 51 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 21%
Student > Bachelor 6 11%
Student > Postgraduate 5 9%
Other 4 7%
Student > Ph. D. Student 4 7%
Other 14 25%
Unknown 11 20%
Readers by discipline Count As %
Medicine and Dentistry 17 30%
Agricultural and Biological Sciences 11 20%
Biochemistry, Genetics and Molecular Biology 5 9%
Neuroscience 2 4%
Immunology and Microbiology 2 4%
Other 5 9%
Unknown 14 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2022.
All research outputs
#15,384,302
of 22,888,307 outputs
Outputs from PLOS ONE
#131,336
of 195,180 outputs
Outputs of similar age
#112,707
of 179,090 outputs
Outputs of similar age from PLOS ONE
#2,883
of 4,731 outputs
Altmetric has tracked 22,888,307 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 195,180 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,090 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4,731 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.